What Is the Evidence for Harm of Neuromuscular Blockade and Corticosteroid Use in the Intensive Care Unit?

Seminars in Respiratory and Critical Care Medicine

Volumn 37, Issue 1, 2016, Pages 51-56

  Annane, Djillali ^a  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

corticosteroids; critical illness neuromyopathy; ICU; neuromuscular blockade

Indexed keywords

ATRACURIUM BESILATE; CORTICOSTEROID; NEUROMUSCULAR BLOCKING AGENT; PANCURONIUM; SUXAMETHONIUM; TUBOCURARINE CHLORIDE;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; ASTHMA; ASTHMATIC STATE; AUTOIMMUNE DISEASE; AUTONOMIC NEUROPATHY; BRADYCARDIA; CARDIOVASCULAR DISEASE; CATHETER INFECTION; CENTRAL CORE DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL (TOPIC); COMMUNITY ACQUIRED PNEUMONIA; CORTICOSTEROID THERAPY; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DEPRESSED BLOOD PRESSURE; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL INFECTION; HOSPITAL INFECTION; HUMAN; HYPERGLYCEMIA; HYPERKALEMIA; HYPERNATREMIA; HYPERTENSION; HYPOKALEMIA; INFECTION; INFLAMMATORY DISEASE; INJURY; INTENSIVE CARE UNIT; LUNG INFECTION; MALIGNANT HYPERTHERMIA; MALIGNANT NEOPLASTIC DISEASE; META ANALYSIS (TOPIC); METABOLIC ALKALOSIS; METABOLIC DISORDER; MUSCLE FATIGUE; MUSCLE WEAKNESS; MYOPATHY; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR DISEASE; PARESIS; PATIENT HARM; PRIORITY JOURNAL; SECONDARY INFECTION; SEPSIS; SEPTIC SHOCK; SHIVERING; SUPERINFECTION; SYSTEMATIC REVIEW (TOPIC); TACHYCARDIA; URINARY TRACT INFECTION; VAGUS NERVE DISEASE; ADVERSE EFFECTS; ARTIFICIAL VENTILATION; ENDOTRACHEAL INTUBATION; INTENSIVE CARE; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY DISTRESS SYNDROME, ADULT; SEVERITY OF ILLNESS INDEX; STANDARDS;

ADRENAL CORTEX HORMONES; CRITICAL CARE; CRITICAL ILLNESS; HUMANS; INTENSIVE CARE UNITS; INTUBATION, INTRATRACHEAL; NEUROMUSCULAR BLOCKADE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; SEPSIS; SEVERITY OF ILLNESS INDEX;

EID: 84961347232     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0035-1570355     Document Type: Article

References (42)

1. Taylor P. Agents acting at the neuromuscular junction and autonomic ganglia. In: Brunton L. L., Lazo J. S., Parker K. L., eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 11th ed. New York McGraw-Hill Companies: 2006; 217 236
2. Ramamoorthy S., Cidlowski J. A. Exploring the molecular mechanisms of glucocorticoid receptor action from sensitivity to resistance. Endocr Dev: 2013; 24 41 56
3. Feldman S. A., Fauvel N. Onset of neuromuscular block. In: Pollard B. J., ed. Applied Neuromuscular Pharmacology. Oxford Oxford University Press: 1994; 69 84
4. Bevan D. R. Newer neuromuscular blocking agents. Pharmacol Toxicol: 1994; 74 1 3 9
5. Mosier J. M., Sakles J. C., Stolz U., et al. Neuromuscular blockade improves first-attempt success for intubation in the intensive care unit. A propensity matched analysis. Ann Am Thorac Soc: 2015; 12 5 734 741
6. Phipps P., Garrard C. S. The pulmonary physician in critical care. 12: Acute severe asthma in the intensive care unit. Thorax: 2003; 58 1 81 88
7. Freebairn R. C., Derrick J., Gomersall C. D., Young R. J., Joynt G. M. Oxygen delivery, oxygen consumption, and gastric intramucosal pH are not improved by a computer-controlled, closed-loop, vecuronium infusion in severe sepsis and septic shock. Crit Care Med: 1997; 25 1 72 77
8. Papazian L., Forel J. M., Gacouin A., et al. ACURASYS Study Investigators Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med: 2010; 363 12 1107 1116
9. Alhazzani W., Alshahrani M., Jaeschke R., et al. Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials. Crit Care: 2013; 17 2 R43
10. Abroug F., Ouanes I., Abroug S., et al. Systemic corticosteroids in acute exacerbation of COPD: a meta-analysis of controlled studies with emphasis on ICU patients. Ann Intensive Care: 2014; 4 32
11. Alía I., de la Cal M. A., Esteban A., et al. Efficacy of corticosteroid therapy in patients with an acute exacerbation of chronic obstructive pulmonary disease receiving ventilatory support. Arch Intern Med: 2011; 171 21 1939 1946
12. Walters J. A., Tan D. J., White C. J., Gibson P. G., Wood-Baker R., Walters E. H. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev: 2014; 9 CD001288
13. Shafiq M., Mansoor M. S., Khan A. A., Sohail M. R., Murad M. H. Adjuvant steroid therapy in community-acquired pneumonia: a systematic review and meta-analysis. J Hosp Med: 2013; 8 2 68 75
14. Annane D. Corticosteroids and pneumonia: time to change practice. Lancet: 2015; 385 9977 1484 1485
15. Funk D., Doucette S., Pisipati A., Dodek P., Marshall J. C., Kumar A. Cooperative Antimicrobial Therapy of Septic Shock Database Research Group Low-dose corticosteroid treatment in septic shock: a propensity-matching study. Crit Care Med: 2014; 42 11 2333 2341
16. Annane D., Bellissant E., Bollaert P. E., Briegel J., Keh D., Kupfer Y. Corticosteroids for treating sepsis. Cochrane Database Syst Rev: 2004; 1 CD002243
17. Ruan S. Y., Lin H. H., Huang C. T., Kuo P. H., Wu H. D., Yu C. J. Exploring the heterogeneity of effects of corticosteroids on acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care: 2014; 18 2 R63
18. Marik P. E., Meduri G. U., Rocco P. R., Annane D. Glucocorticoid treatment in acute lung injury and acute respiratory distress syndrome. Crit Care Clin: 2011; 27 3 589 607
19. Edwards P., Arango M., Balica L., et al. CRASH trial collaborators Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months. Lancet: 2005; 365 9475 1957 1959
20. Roquilly A., Mahe P. J., Seguin P., et al. Hydrocortisone therapy for patients with multiple trauma: the randomized controlled HYPOLYTE study. JAMA: 2011; 305 12 1201 1209
21. Asehnoune K., Seguin P., Allary J., et al. Corti-TC Study Group Hydrocortisone and fludrocortisone for prevention of hospital-acquired pneumonia in patients with severe traumatic brain injury (Corti-TC): a double-blind, multicentre phase 3, randomised placebo-controlled trial. Lancet Respir Med: 2014; 2 9 706 716
22. Dellinger R. P., Levy M. M., Rhodes A., et al. Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med: 2013; 39 2 165 228
23. de Lange D. W., Meulenbelt J. Do corticosteroids have a role in preventing or reducing acute toxic lung injury caused by inhalation of chemical agents? Clin Toxicol (Phila): 2011; 49 2 61 71
24. Venet F., Plassais J., Textoris J., et al. Low-dose hydrocortisone reduces norepinephrine duration in severe burn patients: a randomized clinical trial. Crit Care: 2015; 19 21
25. Mauger B., Marbella A., Pines E., Chopra R., Black E. R., Aronson N. Implementing quality improvement strategies to reduce healthcare-associated infections: a systematic review. Am J Infect Control: 2014; 42 (10, Suppl): S274 S283
26. Hamele M., Stockmann C., Cirulis M., et al. Ventilator-associated pneumonia in pediatric traumatic brain injury. J Neurotrauma: 2015;. doi:10.1089/neu.2015.4004
27. Al-Dorzi H. M., El-Saed A., Rishu A. H., Balkhy H. H., Memish Z. A., Arabi Y. M. The results of a 6-year epidemiologic surveillance for ventilator-associated pneumonia at a tertiary care intensive care unit in Saudi Arabia. Am J Infect Control: 2012; 40 9 794 799
28. Lascarrou J. B., Le Gouge A., Dimet J., et al. Neuromuscular blockade during therapeutic hypothermia after cardiac arrest: observational study of neurological and infectious outcomes. Resuscitation: 2014; 85 9 1257 1262
29. Keh D., Boehnke T., Weber-Cartens S., et al. Immunologic and hemodynamic effects of low-dose hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med: 2003; 167 4 512 520
30. Lamontagne F., Briel M., Guyatt G. H., Cook D. J., Bhatnagar N., Meade M. Corticosteroid therapy for acute lung injury, acute respiratory distress syndrome, and severe pneumonia: a meta-analysis of randomized controlled trials. J Crit Care: 2010; 25 3 420 435
31. Sprung C. L., Annane D., Keh D., et al. CORTICUS Study Group Hydrocortisone therapy for patients with septic shock. N Engl J Med: 2008; 358 2 111 124
32. De Jonghe B., Sharshar T., Lefaucheur J. P., et al. Groupe de Réflexion et d'Etude des Neuromyopathies en Réanimation Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA: 2002; 288 22 2859 2867
33. De Jonghe B., Bastuji-Garin S., Durand M. C., et al. Groupe de Réflexion et d'Etude des Neuromyopathies en Réanimation Respiratory weakness is associated with limb weakness and delayed weaning in critical illness. Crit Care Med: 2007; 35 9 2007 2015
34. Sharshar T., Bastuji-Garin S., Stevens R. D., et al. Groupe de Réflexion et d'Etude des Neuromyopathies En Réanimation Presence and severity of intensive care unit-acquired paresis at time of awakening are associated with increased intensive care unit and hospital mortality. Crit Care Med: 2009; 37 12 3047 3053
35. MacFarlane I. A., Rosenthal F. D. Severe myopathy after status asthmaticus. Lancet: 1977; 2 8038 615
36. Watling S. M., Dasta J. F. Prolonged paralysis in intensive care unit patients after the use of neuromuscular blocking agents: a review of the literature. Crit Care Med: 1994; 22 5 884 893
37. Lacomis D., Giuliani M. J., Van Cott A., Kramer D. J. Acute myopathy of intensive care: clinical, electromyographic, and pathological aspects. Ann Neurol: 1996; 40 4 645 654
38. Schakman O., Kalista S., Barbé C., Loumaye A., Thissen J. P. Glucocorticoid-induced skeletal muscle atrophy. Int J Biochem Cell Biol: 2013; 45 10 2163 2172
39. Puthucheary Z., Rawal J., Ratnayake G., Harridge S., Montgomery H., Hart N. Neuromuscular blockade and skeletal muscle weakness in critically ill patients: time to rethink the evidence? Am J Respir Crit Care Med: 2012; 185 9 911 917
40. Thapa S., Brull S. J. Succinylcholine-induced hyperkalemia in patients with renal failure: an old question revisited. Anesth Analg: 2000; 91 1 237 241
41. Rosenberg H., Davis M., James D., Pollock N., Stowell K. Malignant hyperthermia. Orphanet J Rare Dis: 2007; 2 21
42. Warrington T. P., Bostwick J. M. Psychiatric adverse effects of corticosteroids. Mayo Clin Proc: 2006; 81 10 1361 1367